Ensign Peak Advisors’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,910
Closed -$226K 1801
2022
Q3
$226K Buy
20,910
+2,120
+11% +$22.9K ﹤0.01% 1828
2022
Q2
$214K Hold
18,790
﹤0.01% 1774
2022
Q1
$171K Hold
18,790
﹤0.01% 1920
2021
Q4
$280K Buy
+18,790
New +$280K ﹤0.01% 1838